Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

About 67% of Aziyo Biologics' investor base is looking to short. The analysis of current outlook of investing in Aziyo Biologics suggests that many traders are alarmed regarding Aziyo Biologics' prospects. Aziyo Biologics' investing sentiment overview a quick insight into current market opportunities from investing in Aziyo Biologics. Many technical investors use Aziyo Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
- All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 Aziyo Biologics, Inc. , a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and reported financial results for the first quarter ended March 31, 2023. Business Highlights Net sales rose 14 percent compared to the pr

Read at finance.yahoo.com
Yahoo News
  

Aziyo Biologics Fundamental Analysis

We analyze Aziyo Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aziyo Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aziyo Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

49.2M799.5M687.8M388.5M100%
Aziyo Biologics is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Aziyo Biologics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aziyo Biologics stock to make a market-neutral strategy. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics with similar companies.

Peers

Aziyo Biologics Related Equities

ESTAEstablishment Labs   17.94   
0%
85.0%
LNSRLENSAR   14.78   
0%
70.0%
IRIXIRIDEX   5.11   
0%
24.0%
NVNOEnVVeno Medical   1.15   
0%
5.0%
SRDXSurModics   1.01   
0%
4.0%
NXLNexalin Technology   0.37   
0%
1.0%
ANIKAnika Therapeutics   0.11   
1.0%
0%
AXGNAxogen   0.15   
1.0%
0%
AORTArtivion   0.55   
2.0%
0%
SSKNSTRATA Skin   1.12   
5.0%
0%
OFIXOrthofix Medical   1.43   
6.0%
0%
AIMDAinos   1.75   
8.0%
0%
ELMDElectromed   2.29   
10.0%
0%
AVNSAvanos Medical   2.62   
12.0%
0%
CVRXCVRx   5.26   
24.0%
0%
SGHTSight Sciences   6.05   
28.0%
0%
AIMDWAinos   21.05   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stocks Directory
Find actively traded stocks across global markets
News Freq…Investor S…